Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram.

Pharmacogenetics and genomics - 1 Oct 2021

Su Yun-Ai, Bousman Chad A, Liu Qi, Lv Xiao-Zhen, Li Ji-Tao, Lin Jing-Yu, Yu Xin, Tian Li, Si Tian-Mei

Abstract excerpt

OBJECTIVES: Genome-wide analyses of antidepressant response have suggested that genes initially associated with risk for schizophrenia may also serve as promising candidates for selective serotonin reuptake inhibitor (SSRI) efficacy. Protein tyrosine phosphatase, receptor-type, zeta-1 (PTPRZ1) has previously been shown to be associated with schizophrenia, but it has not been investigated as a predictor of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anxiety
Share to Citalopram

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Genetic Variation

Share to Genome-Wide Association Study

Share to Selective Serotonin Reuptake Inhibitors

Share to Treatment Outcome

Source

Identifiers

PMID: 34081644
DOI: 10.1097/FPC.0000000000000437

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram.PMID 34081644Read ↗

Whole-genome sequencing reveals KRTAP1-1 as a novel genetic variant associated with antidepressant treatment outcomes.Semantic proximity Read ↗

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant responseSemantic proximity Read ↗

Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.Semantic proximity Read ↗

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.Semantic proximity Read ↗

<em>5-HTR1A</em> and <em>5-HTR2A </em>genetic polymorphisms and SSRI antidepressant response in depressive Chinese patientsSemantic proximity Read ↗

A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder.Semantic proximity Read ↗

The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort.Semantic proximity Read ↗

Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.Semantic proximity Read ↗

5-HTTLPR-rs25531 and Antidepressant Treatment Outcomes in Korean Patients with Major Depression.Semantic proximity Read ↗

5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated With Citalopram in a 12-Weeks Follow Up StudySemantic proximity Read ↗

Remission Is not Associated with DRD2 rs1800497 and DAT1 rs28363170 Genetic Variants in Male Schizophrenic Patients after 6-months Monotherapy with Olanzapine.Semantic proximity Read ↗

HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.